Theradaptive

Funding and NIH signals

• SEC Form D raise Raised $36.16M (Form D filed Aug 4, 2026). SEC Form D 0002148461-26-000001 (Aug 4, 2026)
  Evidence (1 event)

  • Aug 4, 2026 · SEC Form D 0002148461-26-000001
    Name of Issuer: Theradaptive, Inc.; CIK: 2148461; Address: Frederick, MD; Submission type: D; Filing date: 2026-08-04; Industry Group: Biotechnology; Date of First Sale: 2026-07-21; Types of Securities Offered: Equity; Business combination transaction: false; Total Offering Amount: 77925166; Total Amount Sold: 36156177; Federal exemptions: 06b

Job counts as of Oct 18, 2026. All funding and NIH signals